Conatus Pharmaceuticals Reports First Quarter 2019 Financial Results and Program Updates
SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the first quarter ended March 31, 2019, and provided updates on its development programs. Program Updates The company is currently …